Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methotrexate With Microneedling Versus Triamcinilone Acetonide With Microneedling in Treatment of Recalcitrant Alopecia Areata

NCT06088147 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT06088147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06088147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methotrexate With Microneedling Versus Triamcinilone Acetonide With Microneedling in Treatment of Recalcitrant Alopecia Areata
Lead sponsor
Al-Azhar University
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2023
Completion date
June 30, 2024
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata